Streaming Giants Intensify Content Race With Weekend Premieres Across Netflix Hulu Prime Video and Apple TV
Treasury Rejects Proposal to Slash VAT on Public EV Charging Sources Say
TIC Solutions Price Target Raised Following Mixed FirstQuarter Performance
SpaceX Scrubs Starship Test Flight Reschedules for Friday as V3 Debut Approaches
HighFlying Stocks Resist Splits Which May Be Next to Crack
Intuit Inc Expands Enterprise Suite to Target MidMarket Business Growth
LUNR Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Revenue Remains Absent
SBFM Q1 2026 Earnings PreRevenue Biotech Reports Net Loss of 025 Per Share Stock Falls 25
BOBS Q1 2026 Earnings EPS Beats Estimates by Nearly 40 Despite Stock Decline
ALKT Q1 2026 Earnings EPS Miss Sends Stock Higher as Investors Look to Profitability Path
CRBP Q1 2026 Earnings Narrower Loss Beats Estimates but No Revenue and Sharp Share Decline Raise Concerns
CRMD Q1 2026 Earnings Profit Surge Driven by NonOperating Items Revenue Remains Absent
Nuveen Core Equity Alpha Fund JCE Trades Flat Amid Tight Range
PMTV Remains Unchanged at 2523 as Bond Markets Digest Mixed Signals
Nuveen Real Asset Income and Growth Fund JRI Edges Lower as Support Level Comes into Focus
FCPT Stock Slips 05 as Investors Gauge Real Estate Sector Stability
IO Biotech IOBT Holds Steady at 005 as Key Support and Resistance Converge
Vital Farms Q1 2026 Earnings EPS Misses Estimates as Stock Rises 676
DPRO Q1 2026 Earnings WiderthanExpected Loss No Revenue Reported Stock Gains 288
FIS Q1 2026 Earnings EPS Beat Cushions the Blow as Stock Slips
Progyny Inc PGNY Q1 2026 Earnings EPS Misses Estimates as Fertility Benefits Utilization Pressures Margins
LAC Q1 2026 Earnings SmallerThanExpected Loss Amid Development Progress
Glaukos GKOS Q1 2026 Earnings SmallerThanExpected Loss Fails to Lift Shares
SEC Delays Regulatory Exemptions for Tokenized Stock Trading by Crypto Firms
Dogwood Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Amid Continued Preclinical Development
Structure Therapeutics GPCR Shows Modest Gains as Biotech Sentiment Improves